bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-5003

Order Name:
Pharmacogenomics in HLA-A **

 
Useful For:
Reduce risks of drug-induced hypersensitivity by HLA-A*31:01 genotyping test, before Carbamazepine therapy 
 
 
Methodology:
Polymerase Chain Reaction (PCR)/Sequence-Specific Oligonucleotide Probes (SSO)
 
Test List In Profile:
HLA-A*31:31
 
AliasesName:
Pharmacogenetic for HLA A
Drug - induced Hypersensitivity
Carbamazepine Hypersensitivity
HLA-A
A3101
 
 
 
Test Code:
090-71-5003

Order Name:
Pharmacogenomics in HLA-A **

 
Collection Specimen Or Container:
Blood/ K3 EDTA (Lavender Top) 3 mL, 2 tubes
 
Specimen Testing Type:
Whole Blood EDTA, minimum volume 3 mL
 
Sub Mission Container:
Original tube
 
Rejection Criteria:
Hemolysis: Hemolysis interfere
Other: Over Stability will be reject
 
Specimen Stabillity:
Specimen Type Temperature Time
Whole blood, EDTA Ambient Same day
Refrigerated, 2oC to 8oC 7 days
 
 
 
Test Code:
090-71-5003

Order Name:
Pharmacogenomics in HLA-A **

 
Method detail:
PCR sequence-specific oligonucleotide probes (SSOPs)
 
Schedule:
N/A **Sent Out to Ramathibodi
 
Turnaround Time:
Reported within 3-5 days (exception for official holidays)
 
Performing Location:
Ramathibodi
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-5003

Order Name:
Pharmacogenomics in HLA-A **

 
 
Clinical Information:
HLA-A*31:01 Genotyping for determining human leukocyte antigens (HLA) type that related to the risk of drug-induced hypersensitivity; before Carbamazepine, therapy.
For Positive result, should follow Guidelines from the Clinical Pharmacogenomics Implementation Consortium (CPIC).
 
Reference Value:
Negative
 
Interpretation:
An interpretive report will be provided.
 
Clinical Reference:
http://ppmrama.com/the-pharmaceutical-laboratory-of-genetics (Retrieved: 27 Apr 2020)